On the public citation graph

Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?

https://doi.org/10.1093/schbul/sbj011
0 signed · 481 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archpsyc.1991.01810270051007openalex-snapshot
National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia
inferredcites →https://doi.org/10.1001/archpsyc.1991.01810350018003openalex-snapshot
Natural History of Schizophrenia Subtypes
inferredcites →https://doi.org/10.1001/archpsyc.1994.03950100052005openalex-snapshot
Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
inferredcites →https://doi.org/10.1001/archpsyc.56.8.749openalex-snapshot
Generalized Cognitive Deficits in Schizophrenia
inferredcites →https://doi.org/10.1001/archpsyc.59.5.449openalex-snapshot
Evidence for Early-Childhood, Pan-Developmental Impairment Specific to Schizophreniform Disorder
inferredcites →https://doi.org/10.1007/s11920-996-0038-7openalex-snapshot
Cognition in schizophrenia
inferredcites →https://doi.org/10.1016/0006-3223(95)00105-0openalex-snapshot
Symptom stability in geriatric chronic schizophrenic inpatients: A one-year follow-up study
inferredcites →https://doi.org/10.1016/0920-9964(91)90039-topenalex-snapshot
Cognitive functioning and positive and negative symptoms in schizophrenia
inferredcites →https://doi.org/10.1016/j.comppsych.2004.03.006openalex-snapshot
Relationship between psychopathology and cognitive functioning in schizophrenia
inferredcites →https://doi.org/10.1016/j.schres.2003.07.001openalex-snapshot
The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients
inferredcites →https://doi.org/10.1016/s0022-3956(02)00016-xopenalex-snapshot
A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia
inferredcites →https://doi.org/10.1016/s0140-6736(94)90569-xopenalex-snapshot
Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort
inferredcites →https://doi.org/10.1016/s0920-9964(01)00393-0openalex-snapshot
Longitudinal study of symptoms and cognitive function in chronic schizophrenia
inferredcites →https://doi.org/10.1016/s0920-9964(03)00097-5openalex-snapshot
Correlates of cognitive deficits in first episode schizophrenia
inferredcites →https://doi.org/10.1016/s0920-9964(96)00075-8openalex-snapshot
Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study
inferredcites →https://doi.org/10.1016/s0920-9964(96)00098-9openalex-snapshot
Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia
inferredcites →https://doi.org/10.1016/s0920-9964(97)00010-8openalex-snapshot
The functional significance of symptomatology and cognitive function in schizophrenia
inferredcites →https://doi.org/10.1017/s0033291700012976openalex-snapshot
Schizophrenic syndromes, cognitive performance and neurological dysfunction
inferredcites →https://doi.org/10.1017/s0033291797005680openalex-snapshot
IQ and risk for schizophrenia: a population-based cohort study
inferredcites →https://doi.org/10.1037//0894-4105.12.3.426openalex-snapshot
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
inferredcites →https://doi.org/10.1053/comp.2001.24587aopenalex-snapshot
The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia
inferredcites →https://doi.org/10.1093/oxfordjournals.schbul.a006870openalex-snapshot
UCSD Performance-Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults
inferredcites →https://doi.org/10.1093/oxfordjournals.schbul.a033430openalex-snapshot
Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?
inferredcites →https://doi.org/10.1093/schbul/11.3.409openalex-snapshot
Symptomatic and Neuropsychological Components of Defect States
inferredcites →https://doi.org/10.1093/schbul/16.1.147openalex-snapshot
Cognitive Deficits and Thought Disorder: II. An 8-month Followup Study
inferredcites →https://doi.org/10.1093/schbul/20.2.311openalex-snapshot
Flat Affect in Schizophrenia: A Test of Neuropsychological Models
inferredcites →https://doi.org/10.1097/00005053-199701000-00004openalex-snapshot
Cognitive Impairment and Substance Abuse History as Predictors of the Temporal Stability of Negative Symptoms in Schizophrenia
inferredcites →https://doi.org/10.1159/000285058openalex-snapshot
Empirical Assessment of the Factorial Structure of Clinical Symptoms in Schizophrenia
inferredcites →https://doi.org/10.1176/ajp.144.7.889openalex-snapshot
Characteristics of very poor outcome schizophrenia
inferredcites →https://doi.org/10.1176/ajp.147.3.290openalex-snapshot
Clinical correlates of the deficit syndrome of schizophrenia
inferredcites →https://doi.org/10.1176/ajp.151.10.1409openalex-snapshot
One hundred years of schizophrenia: a meta-analysis of the outcome literature
inferredcites →https://doi.org/10.1176/ajp.152.2.197openalex-snapshot
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients
inferredcites →https://doi.org/10.1176/ajp.153.3.321openalex-snapshot
What are the functional consequences of neurocognitive deficits in schizophrenia?
inferredcites →https://doi.org/10.1176/ajp.155.8.1080openalex-snapshot
Symptoms, Cognitive Functioning, and Adaptive Skills in Geriatric Patients With Lifelong Schizophrenia: A Comparison Across Treatment Sites
inferredcites →https://doi.org/10.1176/ajp.156.9.1328openalex-snapshot
Behavioral and Intellectual Markers for Schizophrenia in Apparently Healthy Male Adolescents
inferredcites →https://doi.org/10.1176/appi.ajgp.11.6.610openalex-snapshot
The Course of Functional Decline in Geriatric Patients With Schizophrenia: Cognitive-Functional and Clinical Symptoms as Determinants of Change
inferredcites →https://doi.org/10.1176/appi.ajp.157.4.549openalex-snapshot
Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
inferredcites →https://doi.org/10.1176/appi.ajp.157.9.1514openalex-snapshot
Premorbid Functioning in a National Population of Male Twins Discordant for Psychoses
inferredcites →https://doi.org/10.1176/appi.ajp.159.12.2021openalex-snapshot
Relationship Between Premorbid Functioning and Symptom Severity as Assessed at First Episode of Psychosis
inferredcites →https://doi.org/10.1176/appi.ajp.159.8.1388openalex-snapshot
Correlates of Change in Functional Status of Institutionalized Geriatric Schizophrenic Patients: Focus on Medical Comorbidity
inferredcites →https://doi.org/10.1176/appi.ajp.163.3.418openalex-snapshot
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional Capacity, and Symptoms
inferredcites →https://doi.org/10.1176/jnp.12.1.4openalex-snapshot
Cognitive Correlates of the Negative, Disorganized, and Psychotic Symptom Dimensions of Schizophrenia

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4022264openalex-extracted
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2014.1105openalex-snapshot
Motivational Deficits and Cognitive Test Performance in Schizophrenia
inferred← citeshttps://doi.org/10.1002/9781118337981.ch5openalex-snapshot
Implementing evidence‐based treatments in routine mental health services
inferred← citeshttps://doi.org/10.1002/9781394258949.ch10openalex-snapshot
Schizophrenia and the Psychosis Spectrum
inferred← citeshttps://doi.org/10.1002/9781444327298.ch2openalex-snapshot
The Schizophrenia Construct: Symptomatic Presentation
inferred← citeshttps://doi.org/10.1002/9781444327298.ch23openalex-snapshot
Pharmacology and Neuroscience of Antipsychotic Drugs
inferred← citeshttps://doi.org/10.1002/acp.3423openalex-snapshot
Prospective memory, working memory, planning, and attention in schizophrenia and bipolar disorder: A comparative study
inferred← citeshttps://doi.org/10.1002/ajmg.b.32394openalex-snapshot
Social cognition as an RDoC domain
inferred← citeshttps://doi.org/10.1002/cphy.c180025openalex-snapshot
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
inferred← citeshttps://doi.org/10.1002/j.2040-4603.2019.tb00076.xopenalex-snapshot
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
inferred← citeshttps://doi.org/10.1002/syn.20405openalex-snapshot
Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia
inferred← citeshttps://doi.org/10.1002/wps.20385openalex-snapshot
The current conceptualization of negative symptoms in schizophrenia
inferred← citeshttps://doi.org/10.1007/7854_2021_234openalex-snapshot
Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?
inferred← citeshttps://doi.org/10.1007/7854_2022_387openalex-snapshot
Cognitive Dysfunction as a Risk Factor for Psychosis
inferred← citeshttps://doi.org/10.1007/978-3-032-06209-3_14openalex-snapshot
Relationship Between Cognitive Impairment and Negative Symptoms in Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-3-032-06209-3_4openalex-snapshot
Assessment of Negative Symptoms and of Real-Life Functioning: Critical Areas of Overlap
inferred← citeshttps://doi.org/10.1007/978-3-032-18372-9_10openalex-snapshot
Problems with Cognitive Impairments (Memory and Concentration) in Individuals Living with Serious Mental Illness
inferred← citeshttps://doi.org/10.1007/978-3-032-18372-9_14openalex-snapshot
Problems with Functional Impairments in Daily Living Skills in Individuals Living with Serious Mental Illness
inferred← citeshttps://doi.org/10.1007/978-3-032-18372-9_15openalex-snapshot
Problems with Behaviors of Health and Wellness: Sleep, Dietary Habits, Physical Activity and Healthcare in Individuals Living with Serious Mental Illness
inferred← citeshttps://doi.org/10.1007/978-3-319-97307-4_3openalex-snapshot
Neuroimaging of Neurotransmitter Alterations in Schizophrenia and Its Relevance for Negative Symptoms
inferred← citeshttps://doi.org/10.1007/978-3-540-71147-6_43openalex-snapshot
Negativsymptomatik — Bildgebung
inferred← citeshttps://doi.org/10.1007/978-3-642-19844-1_1openalex-snapshot
Konzeption und Grundlagen einer funktionalen Psycho pharmako therapie
inferred← citeshttps://doi.org/10.1007/978-88-470-2802-9_2openalex-snapshot
Disturbi cognitivi, sintomi e funzionamento psicosociale nella schizofrenia
inferred← citeshttps://doi.org/10.1007/978-94-007-0831-0_1openalex-snapshot
Negative Symptoms Across the Schizophrenia Spectrum: Phenomenological and Neurobiological Perspectives
inferred← citeshttps://doi.org/10.1007/bf03379611openalex-snapshot
Deep Brain Stimulation in Schizophrenia
inferred← citeshttps://doi.org/10.1007/s00115-012-3488-7openalex-snapshot
Frühe Demenz als Leitsyndrom einer Schizophrenie
inferred← citeshttps://doi.org/10.1007/s00115-015-4323-8openalex-snapshot
Hirnstimulationsverfahren zur Behandlung schizophrener Psychosen
inferred← citeshttps://doi.org/10.1007/s00115-021-01065-5openalex-snapshot
Transkranielle elektrische Hirnstimulationsverfahren zur Behandlung der Negativsymptomatik bei Schizophrenie
inferred← citeshttps://doi.org/10.1007/s00213-008-1132-9openalex-snapshot
Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study
inferred← citeshttps://doi.org/10.1007/s00406-020-01188-xopenalex-snapshot
Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders
inferred← citeshttps://doi.org/10.1007/s00406-024-01785-0openalex-snapshot
Association of empathy with clinical symptoms and cognitive function in chronic schizophrenia patients with and without suicide attempts
inferred← citeshttps://doi.org/10.1007/s00406-026-02242-wopenalex-snapshot
Interrelationships of childhood trauma, psychiatric symptoms, neurocognition, and insomnia in chronic schizophrenia: a network perspective
inferred← citeshttps://doi.org/10.1007/s00426-008-0195-xopenalex-snapshot
Distinct conflict resolution deficits related to different facets of Schizophrenia
inferred← citeshttps://doi.org/10.1007/s00787-023-02221-9openalex-snapshot
Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review
inferred← citeshttps://doi.org/10.1007/s10072-021-05787-xopenalex-snapshot
Negative symptoms in Huntington’s disease
inferred← citeshttps://doi.org/10.1007/s11011-018-0339-7openalex-snapshot
Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia
inferred← citeshttps://doi.org/10.1007/s11055-022-01312-5openalex-snapshot
Effectiveness of Attention Networks and the Severity of Positive and Negative Symptomatology in Schizophrenia
inferred← citeshttps://doi.org/10.1007/s11065-018-9388-2openalex-snapshot
Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
inferred← citeshttps://doi.org/10.1007/s11920-006-0069-0openalex-snapshot
Anhedonia in schizophrenia
inferred← citeshttps://doi.org/10.1007/s12035-017-0751-8openalex-snapshot
Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia
inferred← citeshttps://doi.org/10.1007/s12640-018-9868-4openalex-snapshot
In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study
inferred← citeshttps://doi.org/10.1007/s12640-018-9937-8openalex-snapshot
Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients
inferred← citeshttps://doi.org/10.1007/s40263-020-00718-4openalex-snapshot
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
inferred← citeshttps://doi.org/10.1016/b978-0-12-809324-5.24107-2openalex-snapshot
Neuroscience and the Concept of Culpability
inferred← citeshttps://doi.org/10.1016/b978-0-12-813201-2.00008-9openalex-snapshot
22q11.2 deletion syndrome
inferred← citeshttps://doi.org/10.1016/b978-0-12-815012-2.00007-9openalex-snapshot
Negative Symptoms and Their Assessment in Schizophrenia and Related Disorders
inferred← citeshttps://doi.org/10.1016/b978-2-294-74526-3.00004-8openalex-snapshot
Cognition sociale dans la schizophrénie : de la théorie à la pratique
inferred← citeshttps://doi.org/10.1016/b978-2-294-74526-3.00015-2openalex-snapshot
Représentations du travail et réinsertion professionnelle
inferred← citeshttps://doi.org/10.1016/j.ajp.2017.01.013openalex-snapshot
Electroencephalogram alpha-to-theta ratio over left fronto-temporal region correlates with negative symptoms in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.ajp.2017.02.007openalex-snapshot
Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.amp.2015.02.002openalex-snapshot
Remédiation cognitive dans la schizophrénie et les troubles apparentés en pratique quotidienne
inferred← citeshttps://doi.org/10.1016/j.apnu.2011.02.006openalex-snapshot
Effects of an Emotion Management Nursing Program for Patients With Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.bbi.2026.106592openalex-snapshot
A longitudinal analysis of bidirectional relationships between executive functioning and peripheral inflammation in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.biopsych.2015.02.017openalex-snapshot
In Search of Multimodal Neuroimaging Biomarkers of Cognitive Deficits in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.biopsych.2019.09.021openalex-snapshot
Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate
inferred← citeshttps://doi.org/10.1016/j.biopsych.2024.01.022openalex-snapshot
What Is Mental Effort: A Clinical Perspective
inferred← citeshttps://doi.org/10.1016/j.biopsych.2025.06.033openalex-snapshot
Exploring the Pathways Between Early Auditory Processing, Processing Speed, Social Cognition, and Negative Symptoms on Social Functioning in Individuals at Clinical High Risk for Psychosis: A Structural Equation Modeling Approach
inferred← citeshttps://doi.org/10.1016/j.clinph.2021.02.398openalex-snapshot
Event-related potentials to rare visual targets and negative symptom severity in a transdiagnostic psychiatric sample
inferred← citeshttps://doi.org/10.1016/j.comppsych.2015.11.001openalex-snapshot
Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.ejpsy.2026.100362openalex-snapshot
Age-dependent associations between plasma neurofilament light chain protein and symptom severity in treatment-resistant Schizophrenia: a moderation analysis
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2012.03.001openalex-snapshot
Delayed- and early-onset hypotheses of antipsychotic drug action in the negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2012.11.008openalex-snapshot
Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2013.10.017openalex-snapshot
Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2013.11.008openalex-snapshot
Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2013.11.012openalex-snapshot
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2014.03.008openalex-snapshot
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2021.02.008openalex-snapshot
Neurocognitive functions in persistent negative symptoms following a first episode of psychosis
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2024.05.006openalex-snapshot
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2024.12.002openalex-snapshot
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2007.03.010openalex-snapshot
Clinical evaluation of negative symptoms in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2008.10.007openalex-snapshot
Correlations between cognitive performances and psychotic or schizotypal dimensions
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2010.12.005openalex-snapshot
Activities of daily living, social functioning and their determinants in persons with psychotic disorder
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2011.01.010openalex-snapshot
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2015.01.014openalex-snapshot
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2017.11.003openalex-snapshot
Amendment of traditional assessment measures for the negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.genhosppsych.2020.05.011openalex-snapshot
Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2007.10.002openalex-snapshot
Neuropsychological impairment in deficit vs. non-deficit schizophrenia
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2013.08.003openalex-snapshot
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2013.10.010openalex-snapshot
Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2018.07.006openalex-snapshot
The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2020.09.003openalex-snapshot
Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia
inferred← citeshttps://doi.org/10.1016/j.metabol.2021.154847openalex-snapshot
Atypical antipsychotic drugs deregulate the cholesterol metabolism of macrophage-foam cells by activating NOX-ROS-PPARγ-CD36 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2013.09.001openalex-snapshot
Neural substrates underlying effort computation in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2019.09.031openalex-snapshot
Multi-outcome meta-analysis (MOMA) of cognitive remediation in schizophrenia: Revisiting the relevance of human coaching and elucidating interplay between multiple outcomes
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2019.10.019openalex-snapshot
Influence of cognitive reserve in schizophrenia: A systematic review
inferred← citeshttps://doi.org/10.1016/j.neulet.2014.05.034openalex-snapshot
Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neuroimage.2011.07.086openalex-snapshot
Cortico-striatal disconnection within the cingulo-opercular network in schizophrenia revealed by intrinsic functional connectivity analysis: A resting fMRI study
inferred← citeshttps://doi.org/10.1016/j.neuroimage.2018.06.024openalex-snapshot
An approach to directly link ICA and seed-based functional connectivity: Application to schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2012.06.028openalex-snapshot
Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia – A path model investigation
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2019.05.009openalex-snapshot
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2021.108454openalex-snapshot
Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2022.108982openalex-snapshot
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia
inferred← citeshttps://doi.org/10.1016/j.nicl.2015.12.010openalex-snapshot
Verbal memory impairments in schizophrenia associated with cortical thinning
inferred← citeshttps://doi.org/10.1016/j.nicl.2018.02.030openalex-snapshot
Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis
inferred← citeshttps://doi.org/10.1016/j.nicl.2022.103064openalex-snapshot
Cortico-cognition coupling in treatment resistant schizophrenia
inferred← citeshttps://doi.org/10.1016/j.nicl.2022.103119openalex-snapshot
Negative schizophrenic symptoms as prefrontal cortex dysfunction: Examination using a task measuring goal neglect
inferred← citeshttps://doi.org/10.1016/j.pbb.2010.01.010openalex-snapshot
MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2011.06.003openalex-snapshot
Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
inferred← citeshttps://doi.org/10.1016/j.physbeh.2021.113651openalex-snapshot
Wisket rat model of schizophrenia: Impaired motivation and, altered brain structure, but no anhedonia
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2009.01.002openalex-snapshot
Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2011.09.004openalex-snapshot
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2012.04.018openalex-snapshot
Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2017.06.031openalex-snapshot
Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2019.109715openalex-snapshot
Examining bi-anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex coupled with bilateral extracephalic references as a treatment for negative symptoms in non-acute schizophrenia patients: A randomized, double-blind, sham-controlled trial
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2021.110309openalex-snapshot
Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2022.110592openalex-snapshot
Association of empathy with clinical symptoms and cognitive function in Chinese chronic schizophrenia patients with and without deficit syndrome
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2023.110833openalex-snapshot
The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2024.111017openalex-snapshot
Repetitive transcranial magnetic stimulation can improve negative symptoms and/or neurocognitive impairments in the first psychosis episode: A randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.pscychresns.2011.07.012openalex-snapshot
Neural markers of early remission in first-episode schizophrenia: A volumetric neuroimaging study of the parahippocampus
inferred← citeshttps://doi.org/10.1016/j.pscychresns.2015.01.016openalex-snapshot
Impairments of event-related magnetic fields in schizophrenia patients with predominant negative symptoms
inferred← citeshttps://doi.org/10.1016/j.pscychresns.2020.111233openalex-snapshot
Divergent relationship between brain structure and cognitive functioning in patients with prominent negative symptomatology
inferred← citeshttps://doi.org/10.1016/j.psychres.2008.04.016openalex-snapshot
The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2009.01.032openalex-snapshot
Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2011.05.032openalex-snapshot
Negative expectancy appraisals and defeatist performance beliefs and negative symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2012.09.056openalex-snapshot
The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy
inferred← citeshttps://doi.org/10.1016/j.psychres.2013.03.020openalex-snapshot
Negative symptom improvement during cognitive rehabilitation: Results from a 2-year trial of Cognitive Enhancement Therapy
inferred← citeshttps://doi.org/10.1016/j.psychres.2014.07.070openalex-snapshot
Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS)
inferred← citeshttps://doi.org/10.1016/j.psychres.2015.08.034openalex-snapshot
Correlation between neuropsychological and social cognition measures and symptom dimensions in schizophrenic patients
inferred← citeshttps://doi.org/10.1016/j.psychres.2015.09.022openalex-snapshot
Are negative symptoms really related to cognition in schizophrenia?
inferred← citeshttps://doi.org/10.1016/j.psychres.2016.10.070openalex-snapshot
Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2017.09.041openalex-snapshot
Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates
inferred← citeshttps://doi.org/10.1016/j.psychres.2017.10.032openalex-snapshot
Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample
inferred← citeshttps://doi.org/10.1016/j.psychres.2018.06.047openalex-snapshot
The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.psychres.2018.12.011openalex-snapshot
Gender differences in correlates of cognition in first-episode psychosis
inferred← citeshttps://doi.org/10.1016/j.psychres.2018.12.088openalex-snapshot
A meta-analysis of executive dysfunction in patients with schizophrenia: Different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome
inferred← citeshttps://doi.org/10.1016/j.psychres.2019.01.089openalex-snapshot
Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients
inferred← citeshttps://doi.org/10.1016/j.psychres.2019.112554openalex-snapshot
Cognitive functioning in patients with first-episode psychosis stratified by level of negative symptoms: A 1-year follow-up study
inferred← citeshttps://doi.org/10.1016/j.psychres.2020.112989openalex-snapshot
Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2020.113404openalex-snapshot
Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs)
inferred← citeshttps://doi.org/10.1016/j.psychres.2024.116126openalex-snapshot
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2025.116445openalex-snapshot
Neuro- and social-cognition in schizotypal personality disorder and schizophrenia: A spectrum of severity
inferred← citeshttps://doi.org/10.1016/j.psychres.2026.117216openalex-snapshot
Effects of fronto-occipital transcranial alternating current stimulation for treating schizophrenia with prominent negative symptoms: A double-blind, randomized, sham-controlled trial
inferred← citeshttps://doi.org/10.1016/j.psyneuen.2018.11.028openalex-snapshot
The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders
inferred← citeshttps://doi.org/10.1016/j.psyneuen.2020.105121openalex-snapshot
BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia
inferred← citeshttps://doi.org/10.1016/j.rpsm.2013.09.002openalex-snapshot
Ante el nuevo reto de identificar el síndrome negativo de la esquizofrenia
inferred← citeshttps://doi.org/10.1016/j.rpsm.2018.03.001openalex-snapshot
Validación española de la escala de evaluación de los síntomas negativos-16 (NSA-16) en pacientes con esquizofrenia
inferred← citeshttps://doi.org/10.1016/j.rpsmen.2013.10.001openalex-snapshot
The new challenge in identifying the negative syndrome of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.rpsmen.2018.03.002openalex-snapshot
Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2006.05.004openalex-snapshot
Antipsychotic medication and cognitive function in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2006.06.005openalex-snapshot
Verbal fluency impairments among middle-aged and older outpatients with schizophrenia are characterized by deficient switching
inferred← citeshttps://doi.org/10.1016/j.schres.2006.07.024openalex-snapshot
Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: Evidence for specificity of relationships?
inferred← citeshttps://doi.org/10.1016/j.schres.2007.01.003openalex-snapshot
Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2007.02.016openalex-snapshot
Metacognition within narratives of schizophrenia: Associations with multiple domains of neurocognition
inferred← citeshttps://doi.org/10.1016/j.schres.2007.03.016openalex-snapshot
Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: A randomized controlled pilot study
inferred← citeshttps://doi.org/10.1016/j.schres.2007.07.025openalex-snapshot
Clinical global impression of cognition in schizophrenia (CGI-CogS): Reliability and validity of a co-primary measure of cognition
inferred← citeshttps://doi.org/10.1016/j.schres.2008.05.006openalex-snapshot
Communication abnormalities predict functional outcomes in chronic schizophrenia: Differential associations with social and adaptive functions
inferred← citeshttps://doi.org/10.1016/j.schres.2009.01.015openalex-snapshot
Negative symptoms and concordant impairments in attention in schizophrenia: Associations with social functioning, hope, self-esteem and internalized stigma
inferred← citeshttps://doi.org/10.1016/j.schres.2009.02.016openalex-snapshot
Pathways to functional outcomes in schizophrenia: The role of premorbid functioning, negative symptoms and intelligence
inferred← citeshttps://doi.org/10.1016/j.schres.2010.09.020openalex-snapshot
A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2011.07.003openalex-snapshot
Apathy, cognitive deficits and functional impairment in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2011.09.006openalex-snapshot
Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study
inferred← citeshttps://doi.org/10.1016/j.schres.2011.09.014openalex-snapshot
Neurodevelopmental liability to schizophrenia: The complex mediating role of age at onset and premorbid adjustment
inferred← citeshttps://doi.org/10.1016/j.schres.2012.02.008openalex-snapshot
Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2012.10.012openalex-snapshot
Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale
inferred← citeshttps://doi.org/10.1016/j.schres.2012.11.010openalex-snapshot
Attaining and sustaining remission of predominant negative symptoms
inferred← citeshttps://doi.org/10.1016/j.schres.2013.01.005openalex-snapshot
Ecological Momentary Assessment of social functioning in schizophrenia: Impact of performance appraisals and affect on social interactions
inferred← citeshttps://doi.org/10.1016/j.schres.2013.02.035openalex-snapshot
Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care
inferred← citeshttps://doi.org/10.1016/j.schres.2013.04.006openalex-snapshot
Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms
inferred← citeshttps://doi.org/10.1016/j.schres.2013.07.007openalex-snapshot
A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis
inferred← citeshttps://doi.org/10.1016/j.schres.2013.08.008openalex-snapshot
The role of negative symptoms in the context of cognitive remediation for schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2013.11.027openalex-snapshot
Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: A prospective three-year follow-up study
inferred← citeshttps://doi.org/10.1016/j.schres.2013.11.037openalex-snapshot
Effect of intrinsic motivation on cognitive performance in schizophrenia: A pilot study
inferred← citeshttps://doi.org/10.1016/j.schres.2014.03.032openalex-snapshot
It is all in the factors: Effects of cognitive remediation on symptom dimensions
inferred← citeshttps://doi.org/10.1016/j.schres.2014.04.005openalex-snapshot
Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: Analysis of amisulpride vs placebo in three clinical trials
inferred← citeshttps://doi.org/10.1016/j.schres.2014.05.025openalex-snapshot
The role of dysfunctional attitudes in models of negative symptoms and functioning in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2014.10.043openalex-snapshot
Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later
inferred← citeshttps://doi.org/10.1016/j.schres.2015.03.033openalex-snapshot
Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity
inferred← citeshttps://doi.org/10.1016/j.schres.2015.05.021openalex-snapshot
The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: An analysis of the CATIE Schizophrenia Trial
inferred← citeshttps://doi.org/10.1016/j.schres.2015.10.032openalex-snapshot
The association of neurocognitive impairment with diminished expression and apathy in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2016.02.035openalex-snapshot
Current developments and challenges in the assessment of negative symptoms
inferred← citeshttps://doi.org/10.1016/j.schres.2016.03.024openalex-snapshot
Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2 years in individuals at clinical high-risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2016.04.002openalex-snapshot
Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2016.05.009openalex-snapshot
Impaired error processing in late-phase psychosis: Four-year stability and relationships with negative symptoms
inferred← citeshttps://doi.org/10.1016/j.schres.2016.05.014openalex-snapshot
Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases
inferred← citeshttps://doi.org/10.1016/j.schres.2016.05.019openalex-snapshot
Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction
inferred← citeshttps://doi.org/10.1016/j.schres.2016.09.002openalex-snapshot
Identifying a system of predominant negative symptoms: Network analysis of three randomized clinical trials
inferred← citeshttps://doi.org/10.1016/j.schres.2016.10.002openalex-snapshot
Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2017.01.011openalex-snapshot
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study
inferred← citeshttps://doi.org/10.1016/j.schres.2017.01.047openalex-snapshot
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study
inferred← citeshttps://doi.org/10.1016/j.schres.2017.01.055openalex-snapshot
Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS)
inferred← citeshttps://doi.org/10.1016/j.schres.2017.05.042openalex-snapshot
Self-reported cognitive distortions in the psychosis continuum: A Polish 18-item version of the Davos Assessment of Cognitive Biases Scale (DACOBS-18)
inferred← citeshttps://doi.org/10.1016/j.schres.2018.10.007openalex-snapshot
Comparison of prefrontal hemodynamic responses and cognitive deficits between adult patients with autism spectrum disorder and schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2018.10.010openalex-snapshot
Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.schres.2018.10.014openalex-snapshot
Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome
inferred← citeshttps://doi.org/10.1016/j.schres.2019.04.005openalex-snapshot
Validation of the Brief Negative Symptom Scale and its association with functioning
inferred← citeshttps://doi.org/10.1016/j.schres.2019.12.018openalex-snapshot
Expressive deficits and amotivation as mediators of the associations between cognitive problems and functional outcomes: Results from two independent cohorts
inferred← citeshttps://doi.org/10.1016/j.schres.2020.04.019openalex-snapshot
A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2020.05.003openalex-snapshot
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways
inferred← citeshttps://doi.org/10.1016/j.schres.2020.06.029openalex-snapshot
Cognition, negative symptoms, and functional outcome in psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2020.11.020openalex-snapshot
Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered
inferred← citeshttps://doi.org/10.1016/j.schres.2021.01.001openalex-snapshot
Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2022.06.007openalex-snapshot
Normal-range verbal memory in the first-episode of psychosis: Clinical and functional outcomes across 24 months and impact of estimated verbal memory decrement
inferred← citeshttps://doi.org/10.1016/j.schres.2023.01.004openalex-snapshot
Longitudinal changes of cognitive function and its relationship with subdomains of negative symptoms in patients with adult-onset first-episode schizophrenia: A 4-year follow up study
inferred← citeshttps://doi.org/10.1016/j.schres.2024.01.031openalex-snapshot
Cortical volume abnormalities in schizophrenia: Correlations with symptoms and cognitive impairment
inferred← citeshttps://doi.org/10.1016/j.schres.2024.04.016openalex-snapshot
Exploring the interplay between core and mood symptoms in schizophrenia: A network analysis
inferred← citeshttps://doi.org/10.1016/j.schres.2024.06.010openalex-snapshot
Overlap between individual differences in cognition and symptoms of schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2024.06.054openalex-snapshot
Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioning
inferred← citeshttps://doi.org/10.1016/j.schres.2025.01.017openalex-snapshot
Cognitive function at first episode in patients subsequently developing treatment-resistant schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2025.10.015openalex-snapshot
Cerebellar-cortical dysfunction and schizophrenia: Advances in neurocognition and therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.schres.2026.01.018openalex-snapshot
Negative symptoms across developmental stages in psychosis spectrum
showing the first 200 of 439 · page through all 439
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.